Detalhe da pesquisa
1.
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.
Ann Hepatol
; 28(6): 101142, 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468097